Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels

Hypertension

Volumn 33, Issue 5, 1999, Pages 1233-1236

  Campbell, Dunncan J ^a   Kladis, Athena ^a   Briscoe, Todd A ^a   Zhuo, Jialong ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Angiotensin; Angiotensinogen; Bradykinin; Receptors, bradykinin; Renin

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; KININ; RENIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE;

EID: 0032896670     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.5.1233     Document Type: Article

References (30)

1. Carretero OA, Scicli AG. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension. 1991 18(suppl I)-I-58-I-69.
2. Scicli AG, Carretero OA. Renal kallikrein-kinin system Kidney Int. 1986;29:120-130.
3. 2kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol. 1992;262:R72-R76.
4. 2-receptor antagonist, on renal function in conscious normotensive rats. Br J Phamacol. 1992;106:380-386.
5. 2 and nitric oxide. Hypertension. 1997;29:757-762.
6. 2 kinin receptors during metabolic anoxia in the rat isolated atria. Can J Physiol Pharmacol. 1997;75:639-645.
7. Schremmer-Danninger E. Öffner A, Siebeck M, Röscher AA. B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem Biophys Res Commun. 1998; 243:246-252.
8. Chiu N, Reid IA. Role of kinins in basal and furosemide-stimulated renin secretion. J Hypertens. 1997; 15:517-521.
9. Bao G, Gohlke P, Qadri F, Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 1992;20: 74-79.
10. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
11. Yosipiv IV, El-Dahr SS. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II. Am J Physiol. 1995;269:F172-F179.
12. Yamamoto A, Keil LC, Reid IA. Effect of intrarenal bradykinin infusion on vasopressin release in rabbits. Hypertension. 1992;19:799-803.
13. Beierwaltes WH, Prada J, Carretero OA. Kinin stimulation of renin release in isolated rat glomeruli. Am J Physiol. 1985;248:F757-F761.
14. Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc Natl Acad Sci U S A. 1995;92: 8006-8010.
15. 2 binding sites in rat kidney following chronic ACE inhibitor treatment. Kidney Int. 1997;52:1261-1270.
16. Campbell DJ, Lawrence AC, Kladis A, Duncan A-M. Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues. In: Smith AI, ed. Methods in Neurosciences. Orlando, Fla: Academic Press; 1995: 328-343. Peptidases and Neuropeptide Processing; vol 23.
17. Campbell DJ, Lawrence AC, Kladis A, Duncan A-M. Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues. In: Smith AI, ed. Methods in Neurosciences. Orlando, Fla: Academic Press; 1995: 328-343. Peptidases and Neuropeptide Processing; vol 23.
18. Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E. Design of rat renin inhibitory peptides. J Med Chem. 1988;31:1679-1686.
19. Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes. J Pharmacol Exp Ther. 1998;284:799-805.
20. Johansen KB, Marstein S, Aas P. Automated method for the determination of angiotensin-converting enzyme in serum. Scand J Clin Lab Invest. 1987;47:411-414.
21. Yandle T, Richards M, Smith M, Charles C, Livesey J, Espiner E. Assay of endopeptidase-24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. Clin Chem. 1992;38:1785-1791.
22. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension. 1991;18:763-773.
23. Campbell DJ, Kladis A, Duncan A-M. Effects of convening enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994; 23:439-449.
24. Siragy HM, Jaffa AA, Margolius HS. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993;6:863-866.
25. Siragy HM, Jaffa AA, Margolius HS, Carey RM. Renin-angiotensin system modulates renal bradykinin production. Am J Physiol. 1996;271: R1090-R1095.
26. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
27. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31(suppl):349-355.
28. Campbell DJ, Kladis A, Valentijn AJ. Effects of losartan on angiotensin and bradykinin peptides, and angiotensin converting enzyme. J Cardiovasc Pharmacol. 1995;26:233-240.
29. Campbell DJ, Rong P, Kladis A, Rees B, Skinner SL. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension. 1995;25: 1014-1020.
30. 2-receptor gene. Circulation. 1997;96:3570-3578.